Eli Lilly Addresses Competition Over Retatrutide Imitations | Retatrutide News

Eli Lilly is addressing the emergence of retatrutide copycats, highlighting competition in the GLP-1 drug market. This move underscores the importance o...
Market News · October 10, 2026